146 related articles for article (PubMed ID: 37678871)
1. Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjögren's Syndrome.
Fang W; Qingqing Z; Qihui L; Bing Z; Xinyue H; Jie X
Altern Ther Health Med; 2023 Nov; 29(8):656-662. PubMed ID: 37678871
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study.
Yoon CH; Lee HJ; Lee EY; Lee EB; Lee WW; Kim MK; Wee WR
J Korean Med Sci; 2016 Jul; 31(7):1127-35. PubMed ID: 27366013
[TBL] [Abstract][Full Text] [Related]
3. Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review.
Zhang A; Chen S; Lin R
Immun Inflamm Dis; 2023 Oct; 11(10):e1044. PubMed ID: 37904705
[TBL] [Abstract][Full Text] [Related]
4. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
Wang SQ; Zhang LW; Wei P; Hua H
BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
[TBL] [Abstract][Full Text] [Related]
5. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the efficacy and safety of herbal decoction CheReCunJin alone and combined with hydroxychloroquine for treating primary Sjögren's syndrome: A randomized controlled trial.
Shao Q; Jin L; Li C; Wang J; Wang M; Wang Q; Wu B
Explore (NY); 2022; 18(4):416-422. PubMed ID: 34417112
[TBL] [Abstract][Full Text] [Related]
8. Long-term hydroxychloroquine therapy improves the quality of sleep in patients with primary Sjögren's syndrome: a real-world study.
Guan P; Sun C; Chen Z; Chen J; Ran R
Ann Palliat Med; 2020 Jul; 9(4):2203-2210. PubMed ID: 32692242
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of iguratimod combined with methylprednisolone for primary Sjögren's syndrome: a meta-analysis and trial sequential analysis.
Hu G; Yu YF; Yin S; Yang XY; Xu Q; You H
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7544-7556. PubMed ID: 37667931
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome.
Gao M; Zhao L; Liang R; Zhu Q; Zhao Q; Kong X
Ocul Immunol Inflamm; 2023 Oct; 31(8):1662-1668. PubMed ID: 35914303
[TBL] [Abstract][Full Text] [Related]
13. Chemokine tear levels in primary Sjögren's syndrome and their relationship with symptoms.
Hernández-Molina G; Ruiz-Quintero N; Lima G; Hernández-Ramírez D; Llorente-Chávez A; Saavedra-González V; Jiménez-Soto R; Llorente L
Int Ophthalmol; 2022 Aug; 42(8):2355-2361. PubMed ID: 35059930
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome.
Yavuz S; Asfuroğlu E; Bicakcigil M; Toker E
Rheumatol Int; 2011 Aug; 31(8):1045-9. PubMed ID: 20309693
[TBL] [Abstract][Full Text] [Related]
15. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Iguratimod in Treating Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Pu J; Wang X; Riaz F; Zhang T; Gao R; Pan S; Wu Z; Liang Y; Zhuang S; Tang J
Front Pharmacol; 2021; 12():621208. PubMed ID: 33815105
[No Abstract] [Full Text] [Related]
17. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
18. Dry eye in Sjögren's syndrome - characteristics and therapy.
Caban M; Omulecki W; Latecka-Krajewska B
Eur J Ophthalmol; 2022 Nov; 32(6):3174-3184. PubMed ID: 35354331
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine.
Collins A; Lendrem D; Wason J; Tarn J; Howard-Tripp N; Bodewes I; Versnel MA; Gottenberg JE; Seror R; Mariette X; Ng WF
Rheumatol Int; 2021 Sep; 41(9):1593-1600. PubMed ID: 34165604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
